Alta Wealth Advisors’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,546
Closed -$288K 144
2022
Q4
$288K Sell
2,546
-132
-5% -$14.5K 0.19% 123
2022
Q3
$216K Sell
2,678
-1,598
-37% -$135K 0.15% 128
2022
Q2
$318K Sell
4,276
-436
-9% -$39.8K 0.22% 117
2022
Q1
$603K Sell
4,712
-60
-1% -$6.56K 0.36% 86
2021
Q4
$641K Sell
4,772
-348
-7% -$50K 0.4% 79
2021
Q3
$700K Sell
5,120
-52
-1% -$6.56K 0.51% 67
2021
Q2
$552K Buy
5,172
+60
+1% +$5.76K 0.4% 92
2021
Q1
$459K Sell
5,112
-236
-4% -$22.2K 0.38% 93
2020
Q4
$494K Buy
+5,348
New +$478K 0.42% 85

Other funds holding DXCM

Alta Wealth Advisors's DXCM Position: Q1 2023 in Review

Alta Wealth Advisors sold out of DexCom (DXCM) in Q1 2023, closing a stake of 2,546 shares — an estimated $288K sold.

Alta Wealth Advisors first reported a position in DXCM in Q4 2020 and held it in 9 quarters. The position peaked at $700K in Q3 2021. 904 funds tracked by Wall St. Rank hold DXCM as of Q1 2023.

  • Alta Wealth Advisors reported no remaining DexCom position as of Q1 2023 after selling out during the quarter.
  • Alta Wealth Advisors sold 2,546 DexCom shares in Q1 2023, an estimated $288K.
  • Alta Wealth Advisors first reported a position in DexCom in Q4 2020 and held it in 9 quarters.
  • Alta Wealth Advisors's DexCom position peaked at $700K in Q3 2021.
  • 904 funds tracked by Wall St. Rank held DexCom as of Q1 2023.

Based on Alta Wealth Advisors's 13F filing for Q1 2023, filed 21 Apr 2023.